实用中医药杂志2024,Vol.40Issue(10) :1924-1926.

保妇康栓治疗高危型人乳头瘤病毒感染临床观察

刘美芳
实用中医药杂志2024,Vol.40Issue(10) :1924-1926.

保妇康栓治疗高危型人乳头瘤病毒感染临床观察

刘美芳1
扫码查看

作者信息

  • 1. 九江学院附属医院妇科,江西 九江 332000
  • 折叠

摘要

目的:观察保妇康栓治疗高危型人乳头瘤病毒(HPV)感染的疗效.方法:86例用随机双盲法分为两组各43例,实验组用保妇康栓外用治疗,对照组用ɑ-2b干扰素栓外用治疗.结果:总有效率实验组高于对照组(P<0.05).治疗后实验组CD3+、CD4+水平高于对照组而CD8+水平低于对照组(P<0.05).治疗后实验组阴道分泌物pH值、Nugent评分低于对照组(P<0.05).不良反应发生率实验组低于对照组(P<0.05).结论:保妇康栓治疗高危型HPV感染疗效较好,且安全.

Abstract

Objective:To observe the efficacy of Baofukang Suppository in the treatment of high-risk human papillomavirus(HPV)infection.Methods:Eighty-six patients were randomly divided into two groups with a double-blind method,with 43 patients in each group.The experimental group received external treatment with Baofukang Suppository,while the control group received external treatment with α-2b Interferon Suppository.Results:The total effective rate was higher in the experimental group than the control group(P<0.05).After treatment,the levels of CD3+and CD4+were higher,while the level of CD8+was lower in the experimental group compared to the control group(P<0.05).Additionally,the pH value of vaginal secretions and Nugent score were lower in the experimental group than the control group after treatment(P<0.05).The incidence of adverse reactions was lower in the experimental group compared to the control group(P<0.05).Conclusion:Baofukang Suppository is effective and safe in the treatment of high-risk HPV infection.

关键词

高危型HPV感染/保妇康栓/对照治疗观察

Key words

High-risk HPV infection/Baofukang Suppository/Control treatment and observation

引用本文复制引用

出版年

2024
实用中医药杂志
重庆医科大学中医药学院

实用中医药杂志

影响因子:0.546
ISSN:1004-2814
段落导航相关论文